May 18th, 2012
Posted on 16. Mar, 2011 by PublicWire in Uncategorized
(WNDM.OB)Wound Management Technologies, Inc. (CellerateRX) Begins Direct To Consumer Television Sales Program
(PublicWire.com News Release) Wound Management Technologies, Inc., (WNDM) a leader in advanced wound care solutions, today announced the commencement of its direct-to-consumer television sales program for CellerateRX(R), its activated collagen wound care product. TV Goods produced the commercial spot and the program is being distributed by MED3TV, LLC.
According to Deborah Jenkins Hutchinson, President of Wound Management Technologies, “The commencement of the Direct Response sales channel is a win-win for the Company. The consumer market is a new source of revenue that will positively impact our bottom-line in fiscal 2011 and beyond. Additionally, this program will further increase our brand recognition, thus benefiting sales and the overall adoption of our other formulations sold in the ‘professional market’.”
Kevin Harrington, Chairman of H&H Imports Inc. (HNHI 0.71, 0.00, 0.00%) , the parent company of TV Goods states, “We’re excited to be behind a product that we think will have mass market appeal.” Harrington is widely acknowledged as the pioneer and principal architect of the “infomercial” industry. Harrington has financed more than 500 product launches resulting in sales of more than $4 billion worldwide with 20 products reaching individual sales of over $100 million each. Steve Rogai, CEO of H&H Imports added, “The medical category is growing in the direct response industry, and I feel this product can be a definite success.”
Scott Haire, CEO of Wound Management Technologies noted, “Direct-To-Consumer sales will expand the Company’s presence throughout the industry and increase awareness of the Company and our products. We are a fast growing and innovative healthcare company made up of a driven team of seasoned industry professionals that is beginning to be discovered.”
Ronald Mathis, Wound Care Innovations’ Senior Vice President of Marketing and Sales added, “I am confident about how this sales program will be received. The show has a superior production value thanks to the skilled folks at TV Goods. We are excited about our deal with MED3TV, LLC, who will distribute the program to the various major television markets in the U.S.”
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management’s primary focus is the distribution of its unique, patented activated collagen product, CellerateRX(R), which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage. More information can be found on the company’s web sites: http://www.mycelleraterx.com.
Trading Symbols
Wound Management Technologies trades Over The Counter As (OTCBB:WNDM, WNDM.OB, WNDM.OTCBB, WNDM, WMDB.OTCQB)
About PublicWire.com
PublicWire.com is a Small Cap Financial Press Release Company that uses a variety of cutting edge methods to syndicate your Small Cap Press Release to various news and information outlets. Our press releases have consitantly placed the Small Cap Companies we work with on the first result page of major search engines such as Google, Bing, and Yahoo. We work exclusively with Pinksheet and Over The Counter (PK and OTCBB) Companies to ensure maximum exposure for their Press Releases.
To maximize your OTCBB / Pinksheet / Small Cap Company Press Release, call us directly at 407-218-7446.
OTCBB:WNDM, WNDM.OB, WNDM.OTCBB, WNDM, WMDB.OTCQB
The symbols “OTCBB:WNDM, WNDM.OB, WNDM.OTCBB, WNDM, WMDB.OTCQB” reflect the variety of methods Woundcare Management Technologies lists their stock as, and were valid at the time of original publication of this press release.